identify you. If you continue to use this site we will assume that you are happy
If you want to use the sites without cookies or would like to know more, you can do that here.
Select regions whose content you would like to see
FOCUS: Medical device manufacturers that assume that the disclosure of their inventions in a clinical trial setting is in confidence run the risk of having subsequently-filed patents revoked. 16 Apr 2015
The UK's leading medical journal has backed the use of an 'off-label' drug for the treatment of a common eye disease. Avastin, which is only licensed to treat cancer in the UK, is considerably cheaper than Lucentis, the standard treatment in the UK. 07 Apr 2015
This guide was updated in December 2014.
The use of equity incentive arrangements is well recognised within the telecoms industry.
This guide was last updated in August 2011.
This guide is based on UK law. It was written and last reviewed in January 2010. For IT service providers, there are many opportunities to get ahead of the competition by engaging with 'green'...
Pharmaceuticals companies will no longer to able to offer "benefits" to doctors in Germany to encourage them to prescribe their drugs, once an update to the country's criminal code comes into force. 02 Apr 2015
A French regulatory committee has recommended that doctors be given approval to prescribe an unlicensed drug for use in treating macular degeneration, despite a licensed alternative being available. 02 Apr 2015
Join My Out-Law
Already signed up to My Out-Law?